https://www.selleckchem.com/pr....oducts/Monensin-sodi
Renal cell carcinoma (RCC) comprises a variety of pathological entities. Many RCCs are aggressive, demanding efficient targeted and immunetherapeutic strategies. Programmed cell death ligand-1 (PD-L1) is expressed mainly in hematopoietic cells and also in epithelial cells. The aim of this study was to correlate PD-L1 protein expression in a series of RCC tissues with their histo-pathological features. One hundred (n=10 archival, formalin-fixed and paraffin-embedded RCC tissue specimens were analysed by immunohistoc
Like
Comment
Share
